INTERPACE BIOSCIENCES, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Interpace Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Interpace Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 4.39M shares, a 1.71% increase year-over-year.
  • Interpace Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.32M shares, a 1.86% increase from 2022.
  • Interpace Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 4.24M shares, a 2.49% increase from 2021.
  • Interpace Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 4.14M shares, a 2.63% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 4.39M +74K +1.71% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 4.38M +65K +1.51% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 4.37M +63K +1.46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.32M +79K +1.86% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 4.32M +77K +1.82% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 4.31M +82K +1.94% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 4.31M +99K +2.35% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 4.24M +103K +2.49% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 4.24M +77K +1.85% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 4.23M +127K +3.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 4.21M +119K +2.91% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 4.14M +106K +2.63% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 4.17M +127K +3.15% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 4.1M +69K +1.71% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 4.09M +85K +2.12% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 4.03M +283K +7.56% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 4.04M +218K +5.71% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 4.03M +220K +5.77% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 4M +489K +13.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 3.75M +930K +33% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 3.82M +3.79M +13439% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-20
Q2 2019 3.81M -24.1M -86.3% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-01-19
Q1 2019 3.52M -24.3M -87.4% Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-01-19
Q4 2018 2.82M -13M -82.1% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 28.2K -22M -99.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 27.9M +18.3M +189% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 27.9M +23.6M +549% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 15.8M +14M +768% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 22M +20.2M +1113% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 9.66M +7.84M +432% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 4.29M +2.52M +142% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 1.82M +268K +17.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 1.82M -13.8M -88.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 1.82M -13.4M -88.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 1.78M -13.3M -88.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 1.55M -13.4M -89.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 15.7M +716K +4.79% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 15.2M +294K +1.97% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 15M +277K +1.88% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 14.9M +183K +1.24% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 14.9M +198K +1.34% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 14.9M +197K +1.34% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 14.8M -223K -1.49% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 14.7M +133K +0.91% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-05
Q3 2013 14.7M +131K +0.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 14.7M +144K +0.99% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 15M +447K +3.08% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-08-19
Q4 2012 14.6M +145K +1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 14.6M +130K +0.9% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-09-30
Q2 2012 14.6M +156K +1.08% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 14.5M +67K +0.46% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 14.4M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 14.5M +154K +1.08% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 14.4M +124K +0.87% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 14.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 14.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 14.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.